T2	Participants 55 159	intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction
T1	Participants 177 373	value of routine administration of intravenous thrombolytic agents during percutaneous transluminal coronary angioplasty (PTCA) therapy of acute myocardial infarction (MI) has not been determined.
T3	Participants 385 520	we prospectively randomized 122 patients with evolving MI to PTCA therapy with or without adjunctive intravenous streptokinase therapy.
T4	Participants 541 625	Patients with ECG ST segment elevation who presented within 4 hours of symptom onset
T5	Participants 735 820	treated immediately with intravenous heparin (10,000 units) and oral aspirin (325 mg)
T6	Participants 1013 1074	those with suitable coronary anatomy underwent immediate PTCA
T7	Participants 839 892	treatment with placebo or streptokinase (1.5 M units)
